After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
'Even Trump's tariff attack cannot stop India's speed', an American agency gives a surprising reason
US President Donald Trump has imposed heavy tariffs on Indian imports. After this, Indian exporte
Students' protest against reservation continues in Bangladesh. There is a curfew here at 6 pm on
Security has been increased in UP on Friday for Friday prayers. Kanpur has been put on high alert
During the withdrawal of American troops from Afghanistan, the US Defense Ministry Pentagon has m
Indian industrialists Gautam Adani and Mukesh Ambani, who have made their presence felt in the li
While gold continues to dominate headlines with its record-breaking rally, another precious metal
The date of 22 January 2024 is going to be recorded in the pages of history in Ayodhya. The grand
Weather Update Today: Heavy rain from mountains to plains, havoc wreaked havoc in these states
Somewhere the weather has become pleasant due to the torrential rains that dominated the monsoon
The parents of Indian student Naveen Shekharappa Gyangoudar, who was killed in the Ukrainian city
As soon as the user opened the social media app Facebook on his mobile, the account suddenly got
